Avantor, Inc.
AVTR · NYSE
Bulios Fair Price
$10.59
33.2% downside
Current Price
$15.86
According to Bulios Fair Price, AVTR is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Avantor, Inc. is a global leader in providing integrated, high-quality products, services, and solutions for scientific and advanced technologies. Their portfolio includes a wide range of chemicals, laboratory equipment, materials, and other products serving research laboratories, the pharmaceutical industry, biotechnology, healthcare, and other sectors. Avantor is known for its ability to deliver high-quality products and services and is considered a reliable partner for the scientific community. Shares of Avantor, Inc. could be attractive for investors seeking exponential growth in the field of scientific technologies and advanced materials.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Emmanuel Ligner
Employees
13,500
Headquarters
Radnor
Upcoming events
Earnings
Upcoming earnings report